<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To evaluate whether premenopausal women with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) or <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) have increased prevalence of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> after adjustment has been made for known <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We evaluated premenopausal women with APS in comparison with age-matched groups of patients with SLE [positive or negative for anticardiolipin (aCL) antibodies] or <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo> (RA), and healthy subjects </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-three subjects in each group were assessed for <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e>, including a detailed <z:chebi fb="23" ids="18059">lipid</z:chebi> profile </plain></SENT>
<SENT sid="3" pm="."><plain>Ultrasonography of carotid and femoral arteries assessed the intima-media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) and the presence of atherosclerotic plaque </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Atherosclerotic plaques were detected in 5, 2, 4, 1 and 1 subject in the five groups respectively </plain></SENT>
<SENT sid="5" pm="."><plain>APS patients had significantly more affected vessels than RA patients and healthy controls (P=0.042 and P=0.016, respectively), but not compared with SLE patients </plain></SENT>
<SENT sid="6" pm="."><plain>No consistent differences in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>, traditional <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> or <z:chebi fb="23" ids="18059">lipid</z:chebi> parameters were detected among the five groups </plain></SENT>
<SENT sid="7" pm="."><plain>The odds for <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> independently increased 1.19-fold per year of increasing age [95% confidence interval (CI) 1.08-1.31; P=0.001), 1.019-fold per 1 mg/dl increase in <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) (95% CI 1.003-1.036; P=0.020), 1.035-fold per additional 1 g of <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> equivalent cumulative <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> dose (95% CI, 0.996-1.074; P=0.074), and 4.35-fold in the presence of APS or SLE (95% CI 0.75-25.2; P=0.10) </plain></SENT>
<SENT sid="8" pm="."><plain>Neither aCL nor anti-beta(2)GPI antibodies were associated with <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Premenopausal APS and SLE women have an increased prevalence of carotid and femoral plaque that is not accounted for by other predictors of <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo>, including age, <z:chebi fb="23" ids="18059">lipid</z:chebi> parameters and cumulative steroid dose </plain></SENT>
</text></document>